Sichuan Kelun Pharmaceutical Co., Ltd. (SHE:002422)

Market Cap	64.65B +8.2%
Revenue (ttm)	18.27B -4.2%
Net Income	1.83B -14.4%
EPS	1.15 -14.4%
Shares Out	1.59B
PE Ratio	35.35
Forward PE	28.13
Dividend	0.59 (1.42%)
Ex-Dividend Date	May 11, 2026

Volume	10,335,293
Open	39.81
Previous Close	40.65
Day's Range	39.81 - 40.90
52-Week Range	28.14 - 52.78
Beta	-0.19
Analysts	Strong Buy
Price Target	52.62 (+29.86%)
Earnings Date	Aug 27, 2026

About SHE:002422

Sichuan Kelun Pharmaceutical Co., Ltd. researches, develops, produces, and sells infusion and non-infusion pharmaceutical products in China and internationally. The company operates through Chuanning, Botai, and Other Business segments. The company offers infusion products; oral medication and other dosage form; medical devices, such as infusion sets, sterile dispensing and injection syringes, vein detained needles, nebulizer sets, and vacuum blood collection tubes; over-the-counter products; and APIs to treat cardiovascular, IPF, ED, anti-tumo...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1996
• Employees: 20,127
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002422

Financial Performance

In 2025, SHE:002422's revenue was 18.51 billion, a decrease of -15.13% compared to the previous year's 21.81 billion. Earnings were 1.70 billion, a decrease of -42.03%.

Analyst Summary

According to 7 analysts, the average rating for 002422 stock is "Strong Buy." The 12-month stock price target is ¥52.62, which is an increase of 29.86% from the latest price.

Price Target

¥52.62

(29.86% upside)

Analyst Consensus: Strong Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 16, 2026

Data Sources Report a data error